"10.1371_journal.pone.0053190","plos one","2013-01-24T00:00:00Z","Martin Neumann; Ebru Coskun; Lars Fransecky; Liliana H Mochmann; Isabelle Bartram; Nasrin Farhadi Sartangi; Sandra Heesch; Nicola Gökbuget; Stefan Schwartz; Christian Brandts; Cornelia Schlee; Rainer Haas; Ulrich Dührsen; Martin Griesshammer; Hartmut Döhner; Gerhard Ehninger; Thomas Burmeister; Olga Blau; Eckhard Thiel; Dieter Hoelzer; Wolf-Karsten Hofmann; Claudia D Baldus","Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany; Goethe University Hospital, Department of Medicine II, Hematology and Oncology, Frankfurt/Main, Germany; Department of Hematology and Oncology, University of Düsseldorf, Düsseldorf, Germany; Department of Hematology and Oncology, University of Essen, Essen, Germany; Department of Hematology and Oncology, Klinikum Minden, Minden, Germany; Department of Internal Medicine III, University of Ulm, Ulm, Germany; Department of Hematology and Oncology, University of Dresden, Dresden, Germany; University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany","Conceived and designed the experiments: MN NG DH ET CDB. Performed the experiments: MN EC LF LM IB NFS SH SS CS OB. Analyzed the data: MN EC TB CDB. Contributed reagents/materials/analysis tools: CB RH UD MG HD GE. Wrote the paper: MN EC SS WKH CDB.","TKI258 was a kind gift from Novartis (Basel, Switzerland). There are no further patents, products in development or marketed products to declare. This does not alter the authors‚ adherence to all the PLOS ONE policies on sharing data and materials.","2013","01","Martin Neumann","MN",22,TRUE,5,10,4,5,TRUE,TRUE,FALSE,0,NA,FALSE
